title: Association between altered systemic inflammatory interleukin-1beta and natural killer cell activity and subsequently agitation in patients with Alzheimer disease.
abstract: OBJECTIVE
  Alzheimer's disease (AD) is a neurodegenerative disorder that is the most common cause of dementia in the elderly and is frequently accompanied by emotional disorder, including agitation. Although evidence of neuroendocrine immune and inflammatory functions during emotional changes has been accumulated, the pathogenic mechanisms in the development of agitation accompanied by AD remain to be elucidated.
  
  
  METHODS
  To clarify the involvement of neuroendocrine and immune and inflammatory systems in agitation in AD, we examined agitation levels, circadian rhythms of behavior, cortisol, interleukin-1beta (IL-1beta), and natural killer cell activity (NKCA) in controls without dementia and 16 AD patients who were recognized to be easily agitated in their nursing homes. These behavioral and blood indicators were assessed according to the progress of the stage of agitation in 16 AD patients (stable, pre-agitation, and agitation stages).
  
  
  RESULTS
  Elevations in night behavior and blood cortisol, IL-1beta and an reduced blood NKCA level in the evening were observed not only in the agitation stage, but also when stable in AD patients as compared to the control. Increased IL-1beta and decreased NKCA occurred in both the morning and evening in pre-agitation and agitation stages in AD.
  
  
  CONCLUSIONS
  The increased IL-1beta and decreased NKCA with the progress of agitation in AD suggest that inflammation produces agitation and aggravates AD.
authors.affiliation: Department of Environmental and Preventive Medicine, Graduate School of Medical Science, Kanazawa University, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Higuchi
authors.forename: K
authors.initials: K
authors.lastname: Hatta
authors.forename: T
authors.initials: T
authors.lastname: Honma
authors.forename: Y H
authors.initials: YH
authors.lastname: Hitomi
authors.forename: Y
authors.initials: Y
authors.lastname: Kambayashi
authors.forename: Y
authors.initials: Y
authors.lastname: Hibino
authors.forename: I
authors.initials: I
authors.lastname: Matsuzaki
authors.forename: S
authors.initials: S
authors.lastname: Sasahara
authors.forename: H
authors.initials: H
authors.lastname: Nakamura
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000097:blood / Q000150:complications / Q000276:immunology*; D000704:Analysis of Variance; D015415:Biomarkers / Q000097:blood; D002940:Circadian Rhythm; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D053583:Interleukin-1beta / Q000097:blood*; D007694:Killer Cells, Natural / Q000276:immunology*; D008297:Male; D009483:Neuropsychological Tests; D011595:Psychomotor Agitation / Q000097:blood / Q000209:etiology / Q000276:immunology*
chemical_list: D015415:Biomarkers; D053583:Interleukin-1beta; D006854:Hydrocortisone